<DOC>
	<DOCNO>NCT01389596</DOCNO>
	<brief_summary>Study A0081041 double blind , placebo control , randomize , parallel group , multicenter study evaluate safety efficacy two dose level pregabalin administer equally divided daily dos , either capsule oral liquid formulation , adjunctive therapy pediatric subject 4 16 year age partial onset seizure .</brief_summary>
	<brief_title>A Study Efficacy Safety Pregabalin Add-On Therapy Partial Onset Seizures Children Ages 4-16 Years</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Subjects and/or parent ( ) /legally acceptable representative must consider willing able sign consent , complete daily seizure diary monitor seizure frequency . Male female epilepsy subject , 4 16 year age inclusive date Screening Visit . Diagnosis epilepsy partial onset seizure classify simple partial , complex partial partial become secondarily generalize , accord International League Against Epilepsy ( ILAE ) Diagnosis criterion . Must partial onset seizure frequency least 3 seizure per 28 day period prior screen . Must partial onset seizure frequency least 6 seizure continuous 4 week seizure free period 8 week baseline phase prior randomization . Currently receive stable dose 1 3 antiepileptic drug ( stable within 28 day prior screen ) . Primary generalized seizure ( include set coexist partial onset seizure ) include , example : Clonic , tonic clonictonic seizure ( note partial onset seizures become secondarily generalized exclusionary ) ; Absence seizures ; Infantile spasms ; Myoclonic , myoclonic atonic , myoclonic tonic seizure . Lennox Gastaut syndrome , Benign Epilepsy Centrotemporal Spikes ( BECTS ) Dravet syndrome . A current diagnosis febrile seizure , seizure relate ongoing acute medical illness . Any febrile seizure within 1 year screening . Status epilepticus within 1 year prior screen . Seizures related drug , alcohol , acute medical illness . Any change AED regimen ( type medication dose ) within 28 day Screening Visit Baseline Phase . Progressive structural CNS lesion progressive encephalopathy .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
	<keyword>partial onset seizure</keyword>
	<keyword>pediatric</keyword>
	<keyword>pregabalin</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>double-blind</keyword>
</DOC>